Skip site navigation (1)Skip section navigation (2)
Date:      Mon, 27 Jan 2003 11:30:40 -2000
From:      "Investment" <polltis@baysystems.com.pk>
To:        <achor@earthlink.net>
Cc:        <cvs-all@freebsd.org>, <jeffssweet@aol.com>, <sales@decoratorsbox.com>, <blc_cruz20@hotmail.com>, <sascha.uhl@tenovis.com>, <nezofolowo@vimoleri.org>, <dtol@desconnect.com>, <capt.fantastic@worldnet.att.net>, <lewro1@yahoo.com>, <s.g.trapp@worldnet.att.net>, <newsboys_17@yahoo.com.au>
Subject:   Performers1715
Message-ID:  <0000105d747e$00002c2f$00001877@www.vrg.se>

next in thread | raw e-mail | index | archive | help
BUY NASDAQ: MSGL (OTC BB) – Medical Technology Sector;
MRI Scanning Software Systems Groundbreaking Upgrade
Allows 10X more Resolution, at 10% of the cost of a new
machine; 

Proven existing market of $1.3B for this product. The
product is patented, FDA approved and currently just 
beginning to be implemented at many major institutions.  
The software allows for MRI resolutions of up to 1.3 
Tesla’s compared to existing clarity of 0.5 Tesla’s.

Investors who are still making money in the stock market
are those who know what stocks are in play or stocks
about to be promoted/syndicated. By now you probably
realize that stocks don’t just go up but are pushed
up by brokerage firms that give companies exposure and 
analyst coverage – they promote them! To make money, 
an investor needs to buy at the beginning of the PUSH 
and sell within a 60-day period.

We report on which stocks are being pushed and at what 
price levels to buy and sell at. 

Our current pick, OTCBB: MSGL is poised to move quickly
with solid fundamentals, excellent news to be released
continually over the next several weeks and a full-blown
exposure campaign and promotion underway.

Trading Symbol--------MSGL
Exchange Listing------NASDAQ OTCBB
Capital Structure-----Total Float/DTC  5.8m,
of which 4.4 million are tightly held/friendly
Recent High-----------$0.40
Recent Low------------$0.08
30-day Avg Volume-----40,000
30-day price target---$0.50

NASDAQ OTCBB: MSGL - Listed Medical Technology MRI 
Software Company MSGL – Developers of a Revolutionary 
MRI upgrade software package (currently being implemented
in facilities across the U.S.) that produces images with
up to 10X more clarity and resolution than standard MRI
processing software at a fraction of the price.

MSGL’s ground-breading SLICES software manipulates raw 
data matrices obtained through the MRI scanning process. 
Through the use of advanced calculations (MicroSignal's 
EXACT method), SLICES is able to produce images that 
boast up to 10 times more clarity and resolutions than 
standard MRI processing software.

In addition to superior image quality, and because of
the method of processing, SLICES™ is able to significantly
reduce patient scan time and the need for patient call
backs and rescanning. These factors also can contribute
to a reduction in film consumption of up to 40%.

At the end of 2002, there were approximately 10,500 MRI
(magnetic resonance imaging) systems installed worldwide.
While changes in medical reimbursement have slowed the
sale of new MRI machines, and the ever-increasing demand
for improved image quality and reduced patient scan time;
thus there has been a tremendous need for products that
can improve patient throughput and image quality. OTCBB:
MSGL has solved this problem with its low cost software
that upgrades existing installed MRI systems to the quality
of a new machine at a savings of approximately $1.4 million
per machine.

The total estimated market for this system is in excess
of $1.3B. NASDAQ OTCBB: MSGL is expected to capture 
approximately 40% of this market within 3 years, resulting
in revenues of approximately $500 million, with a Net
Margin of approximately 35%, or over $100 million in
earnings.

Other medical technology / software & system developers
such as Baxter Medical NYSE: BAX – p/e of 20X; NASDAQ:
NMMD, p/e of 31.4, NASDAQ: NMDC, p/e of 20X; an average
of 24X current EPS, and 20X 1 yr forward expected earnings.

In comparison to these valuations, NASDAQ OTCBB: MSGL,
with its proven market for its product, sales on the books
for the current quarter and a successful product launch
already would be more fairly valued at 25X–to-30X forward
earnings or $2.00 –to- $3.00 per share currently.

For more information, see the company’s website:
microsignalcorp.com/index2.htm


*******************************************************
***********************Disclaimer********************
Information within this email contains "forward looking
statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21B of the Securities
Exchange Act of 1934. Any statements that express or
involve discussions with respect to predictions, goals,
expectations, beliefs, plans, projections, objectives,
assumptions or future events or performance are not
statements of historical fact and may be "forward
looking statements."

Forward looking statements are based on expectations,
estimates and projections at the time the statements 
are made that involve a number of risks and uncertainties
which could cause actual results or events to differ
materially from those presently anticipated. Forward
looking statements in this action may be identified
through the use of words such as: "projects", "foresee",
"expects", "estimates," "believes," "understands" "will,"
"anticipates," or that by statements indicating certain
actions "may," "could," or "might" occur. All information
provided within this email pertaining to investing, stocks,
securities must be understood as information provided and
not investment advice. Emerging Equity Alert advises all
readers and subscribers to seek advice from a registered
professional securities representative before deciding to
trade in stocks featured within this email. None of the
material within this report shall be construed as any kind
of investment advice.

In compliance with the Securities Act of 1933,
Section 17(b), Emerging Stock Alert discloses the
receipt of 50,000 unrestricted shares of MSGL from
a third party for the publication of this report. Be
aware of an inherent conflict of interest resulting
from such compensation due to our intent to profit from
the liquidation of these shares. Shares may be sold at
any time, even after positive statements have been made
regarding the above company. All factual information in
this report was gathered from public sources, including
but not limited to SEC filings, Company Press Releases,
and Market Guide. Emerging Equity Alert believes this
information to be reliable but can make no guarantee
as to its accuracy or completeness. Use of the material
within this email constitutes your acceptance of these
terms.


****** Advertising Disclaimer ******

We are an internet advertising company and have received
a monetary payment for this mailing service We hold no
stocks and have no personal interest in this company
whatsoever. We are simply being paid to perform a service.

****** Removal Instructions ******
This message has been sent to you in compliance with
our strict anti-abuse regulations. We will continue to
bring you valuable offers on the products and services
that interest you most. If you do not wish to receive
further mailings, please click below. We respect all
removal requests. To be removed immediately from our
mailing lists just click on the link below:
MailTo:cal6517@excite.com
Be sure that "Please Remove" is in the subject line
of the email prior to sending it. This message is a paid
advertisement.


To Unsubscribe: send mail to majordomo@FreeBSD.org
with "unsubscribe cvs-all" in the body of the message




Want to link to this message? Use this URL: <https://mail-archive.FreeBSD.org/cgi/mid.cgi?0000105d747e$00002c2f$00001877>